Product name | Tetramisole Hydrochloride |
CAS No. |
|
Molecular Formula |
C11H13ClN2S
|
Molecular weight |
240.75 |
Grade Standard | Medicine Grade |
Tetramisole was originally used as an anthelminthic to treat worm infestations in both humans and animals. Most current commercial preparations are intended for veterinary use as a dewormer in cattle, pigs, and sheep.
However, tetramisole has also recently gained prominence among aquarists as an effective treatment for Camallanus roundworm infestations in freshwater tropical fish. It is a broad-spectrum anthelminthics, used to control roundworm and hoodworm.
For the prevention and treatment of the hookworm, ascaris, pinworm, whipworm, dung class round worms and other intestinal parasitic disease.
1.For the adjuvant treatment for after surgery of lung cancer, breast cancer or acute leukemia, malignant lymphoma chemotherapy.
2.Can also be used for autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, psoriasis, and upper respiratory tract infection, Pediatric respiratory infections, hepatitis, bacillary dysentery, sore and furuncle, abscess, and so on.
3.The curative effect is distinct in the near future for obstinate bronchial asthma.
4. Used to kill roundworm, hookworm.
Items | Standard | Results |
Identification | specific optical rotation | Qualified |
IR | ||
Gives reaction of chlorides | ||
Solution S | Meets the requirements | Qualified |
PH:3.0~4.5 | 4.1 | |
-121°~-128°
Specific optical rotation:-121°~-128° |
-121° | |
Loss on drying | ≤0.5% | 0.1% |
Residue on ignition: | ≤0.1% | 0.03% |
Related substances | Each of impurities A,B,C,D ≤0.2% |
A: 0.02%, B: 0.01%,
C: 0.09%, D: 0.00% |
≤0.1%
Any other impurity≤0.1% |
0.01% | |
≤0.3%
Total impurities≤0.3% |
0.10% | |
Heavy metals | ≤0.002% | <0.002% |
Microbial limit | Bacteria ≤1000 per gram | Qualified |
Mold&yeast ≤100 per gram | ||
Escherichia Coli : no | ||
Assay | 98.5%~101.0% | 100.1% |
Storage | Should be protected from light | protected from light |
CONCLUSION | The product complies to the standard of BP2011, EP7.0 |
Active Pharmaceuticals